KC Biebighauser Bens, M.D.

KC Biebighauser Bens, M.D.

Dr. KC Biebighauser Bens completed her Bachelor’s degree in Biochemistry at The University of Texas at Austin, and her Medical Doctorate at McGovern Medical School at The University of Texas Health Science Center in Houston. She then went on to complete her surgical internship and urology residency at Emory University in Atlanta, Georgia.

Dr. Bens is trained in all areas of adult urology including minimally invasive surgery. She treats both benign and malignant urologic diseases, in both male and female patients. She has a specific interest in oncologic and reconstructive surgery using the DaVinci Robot. She also commonly treats lower urinary tract symptoms, incontinence and erectile dysfunction.

Dr. Bens currently practices out of Methodist Dallas Medical Center, a level one trauma center and one of the largest hospitals in the DFW Metroplex. She lives nearby in Dallas with her husband, son and two large dogs who keep her busy outside of work. She enjoys running, cycling, traveling, and outdoor activities with her family.

PROFESSIONAL TRAINING

  • Emory University – Atlanta, GA
    – Intern, Department of General Surgery, 2016 – 2017
    – Resident, Department of Urology, 2017 – 2021

EDUCATION

  • McGovern Medical School, University of Texas Health Science Center – Houston, TX
    – Doctor of Medicine, 2016
    – Global Health Scholarly Concentration, 2016
  • University of Texas at Austin – Austin, TX
    – Bachelor of Arts in Biochemistry with Honors, 2006 – 2010

PROFESSIONAL ORGANIZATIONS

  • American Urologic Association
  • Alpha Omega Alpha Honor Medical Society
  • Society of Women in Urology
  • American Medical Women’s Association
  • American Medical Association

HONORS & AWARDS

  • McGovern Medical School – Alpha Omega Alpha Honor Society 2016

LEADERSHIP AND VOLUNTEER ACTIVITIES

  • Curriculum Committee, Department of Urology – Emory University, 2017 – 2021
  • Students Improving Global Health in Texas – Roatan, Honduras, 2013, 2014
  • Work the World – Takoradi, Ghana, 2013

Publications

  • Steinberg RS, Kipling L, Bens KCB, Patil D, Henry M, Mehta A, Filson C. Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy. World J Urol. 2021 Mar 26.
  • Nabavizadeh R, Higgins MI, Patil D, Biebighauser Bens KC, Traore E, Master VA, Ogan K. Overlapping Urological Surgeries at a Tertiary Academic Center. Urology. 2021 Feb;148:118-125.
  • Kirsch AJ, Bens KCB. Editorial Comment. Urology. 2020 Nov;145:295.
  • Patil D, Le TL, Bens KB, Alemozaffar M, Lay A, Pattaras J, Filson CP, Ogan K, Bilen MA, Master VA. Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Resected Localized Clear Cell Renal Cell Carcinoma. Urology. 2020 Jul;141:101-107.
  • Biebighauser K, Gao J, Rao P, Landon G, Pagliaro L, Dinney CPN, Karam J, Navai N. Non-seminomatous Germ Cell Tumor with Bone Only Metastasis at Diagnosis: A Rare Clinical Presentation. Asian J Urol. 2017 Apr;4(2):124-127.

Abstracts and Presentations

  • Ismaeel N, Biebighauser Bens K, Patil D, Ogan K, Filson C, Mehta A, Lay A. An Institutional Assessment of Turnover Time in Urology Cases. Accepted for presentation at the Southeastern Section of the American Urologic Association Meeting, March 2020.
  • Nabavizadeh R, Patil D, Biebighauser Bens K, Traore E, Master V, Ogan K. Overlapping Urologic Surgeries at a Tertiary Academic Center. Accepted for presentation at the Southeastern Section of the American Urologic Association Meeting, March 2020.
  • Biebighauser Bens K, Traore E, Said M, Aliperti L, Pearl J, Alemozaffar M, Filson C. Cost Implications of Perioperative Intravesical Chemotherapy for Bladder Tumor Resection: Gemcitabine versus Mitomycin-C. Presented at the Southeastern Section of the American Urologic Association Meeting, March 2019, and the American Urologic Association Meeting, May 2019.
  • Biebighauser Bens K, Patil D, Kipling L, Henry M, Filson C. Complications after Transperineal and Transrectal Prostate Biopsy among Men with Employer Based Insurance. Presented at the Southeastern Section of the American Urologic Association Meeting, March 2019, and the American Urologic Association Meeting, May 2019.
  • Patil D, Biebighauser Bens K, Alemozaffar M, Lay A, Bilen M, Pattaras J, Filson C, Ogan K, Master V. Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Low Risk Clear Cell Renal Cell Carcinoma.
  • Ismaeel N, Biebighauser Bens K, Patil D, Ogan K, Filson C, Mehta A, Lay A. An Institutional Assessment of Turnover Time in Urology Cases. Presented at SESAUA, March 2020.
  • Nabavizadeh R, Patil D, Biebighauser Bens K, Traore E, Master V, Ogan K. Overlapping Urologic Surgeries at a Tertiary Academic Center. Presented at SESAUA, March 2020.
  • Biebighauser Bens K, Traore E, Said M, Aliperti L, Pearl J, Alemozaffar M, Filson C. Cost Implications of Perioperative Intravesical Chemotherapy for Bladder Tumor Resection: Gemcitabine versus Mitomycin-C. Presented at SESAUA, March 2019 and AUA, May 2019.
  • Biebighauser Bens K, Patil D, Kipling L, Henry M, Filson C. Complications after Transperineal and Transrectal Prostate Biopsy among Men with Employer Based Insurance. Presented at SESAUA, March 2019 and AUA, May 2019.
  • Patil D, Biebighauser Bens K, Alemozaffar M, Lay A, Bilen M, Pattaras J, Filson C, Ogan K, Master V. Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Low Risk Clear Cell Renal Cell Carcinoma. Presented at AUA, May 2019.
  • Williams M, Khan A, Patil D, Biebighauser Bens K, Psutka S, Sekhar A, Ogan K, Bilen M, Master V. Racial Differences in the Prognostic Capabilities of Sarcopenia in Predicting Overall Survival After Surgery for Patients with Localized Renal Cell Carcinoma. Presented at SESAUA, March 2019.
  • Biebighauser Bens, K. Post-Biopsy Complications: Transperineal versus Transrectal Ultrasound-Guided Prostate Biopsy. Presented at the Emory University Department of Urology Annual Research Retreat, 2019.
  • A New and Improved Alternative: Intravesical Gemcitabine for Non-Muscle Invasive Bladder Cancer. Presented at Georgia Urologic Association Meeting, 2019.
  • Kidney stones
  • Erectile dysfunction
  • Low testosterone
  • Enlarged prostate or benign prostatic hyperplasia (BPH)
  • Urinary incontinence (male & female)
  • Pelvic organ prolapse
  • Overactive bladder
  • Urethral stricture
  • Ureteropelvic junction (UPJ) obstruction
  • Ureteral stricture
  • Penile curvature or Peyronie’s Disease
  • Kidney Cancer
  • Ureteral Cancer
  • Bladder Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Penile Cancer
  • Vasectomy
  • Cystoscopy
  • Ureteroscopy
  • Laser lithotripsy
  • Extracorporeal Shockwave Lithotripsy (ESWL)
  • Inflatable penile prosthesis (IPP)
  • Malleable penile prosthesis (MPP)
  • Transurethral resection of prostate (TURP)
  • UroLift
  • Rezūm
  • Macroplastique
  • Artificial urinary sphincter (AUS)
  • Female urethral sling
  • Robotic sacrocolpopexy
  • Prolapse repair
  • Bladder Botox injections
  • Suprapubic tube (SPT) placement
  • Urethral dilation
  • Direct visualized internal urethrotomy (DVIU)
  • Urethroplasty
  • Pyeloplasty
  • Robotic-assisted ureteral reconstruction
  • Penile plication
  • Penile biopsy
  • Robotic-assisted nephrectomy
  • Robotic-assisted partial nephrectomy
  • Robotic-assisted radical nephroureterectomy
  • Transurethral resection of bladder tumor (TURBT)
  • Radical cystectomy, ileal conduit
  • Robotic-assisted laparoscopic radical prostatectomy (RALP)
  • Orchiectomy
  • Hydrocelectomy